Eline Giraud and Elise Smolders on QT interval prolongation potential of anticancer
The Lancet Oncology in conversation with
English - August 30, 2022 22:00 - 11 minutes - 8.04 MB - ★★★★★ - 1 ratingMedicine Health & Fitness Education cancer radiotherapy chemotherapy mrna Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Ignace Vergote and Maria Kyrgiou on gynaecological cancers
Next Episode: Inge Marie Svane on mRNA vaccines for cancer treatment
Eline Giraud and Elise Smolders from the (Radboud University Medical Center, Nijmegen, Netherlands) discuss their Review on QT interval prolongation potential of anticancer and supportive drugs.
Read the full Review:
The QT interval prolongation potential of anticancer and supportive drugs: a comprehensive overview
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv